Intermede Investment Partners LTD Amgen Inc Transaction History

Intermede Investment Partners LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $41.7 Million - $48.8 Million	-246,290 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $1.9 Million - $2.12 Million	11,253 Added 4.79%	246,290 $42.8 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $39.3 Million - $44.9 Million	235,037	235,037 $43.8 Million

3,119

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Intermede Investment Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Intermede Investment Partners LTD with notifications on news.